您的位置: 首页 > 农业专利 > 详情页

Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents
专利权人:
Netris Pharma
发明人:
Royet, Amelie,Mann, Fanny,Chauvet, Sophie,Luchino, Jonathan
申请号:
AU2011249750
公开号:
AU2011249750A1
申请日:
2011.05.06
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
The present invention is related to the treatment of certain cancers using antagonists of the binding between a Plexin and a Sema3E. The invention may be helpful in treating primary cancer cell development and metastasis development wherein Sema3E is expressed, in particular overexpressed by the tumoral cells or the stroma. Breast cancer, in particular with distant metastases is concerned. Prostate cancer, melanoma and glioblastoma are also concerned. The antagonist may be any molecule that specifically binds to PlexinD1 or Sema3E and blocks the Sema3E/PlexinD1 binding. In an embodiment, the antagonist is a polypeptide or an antibody.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充